Added to YB: 2025-02-14
Pitch date: 2025-02-12
GLTO [bullish]
Galecto, Inc.
+589.66%
current return
Author Info
Turtles Research writes short articles about mis-priced boring stocks around the world. Sign up for the newsletter.
Company Info
Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
Market Cap
$35.6M
Pitch Price
$4.64
Price Target
8.00 (-75%)
Dividend
N/A
EV/EBITDA
-2.49
P/E
-2.24
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Reviving two old ideas - Galecto, Inc.
GLTO: $13-14/share net cash vs $4.3 price. $7-10/share 2025 cash burn. Tiny float, strong IP. 18mo runway for sale/licensing. $20-40m buyout potential vs $6m mcap. Speculative but +EV. Good news could drive 40-85% upside. Small position added.
Read full article (1 min)